Current treatments for diabetes primarily include metformin, sulfonylureas, GLP-1 receptor agonists, DPP-4 inhibitors, and sodium-glucose cotransporter 2 (SGLT2) inhibitors. The gene discussed is SLC5A2; the disease is diabetes mellitus.